Schedule 13D ownership disclosure
NAVIDEA BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 63937X202
Event date: 2019-12-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 28.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-312785
- Form type
- SC 13D
- Filer
- NAVIDEA BIOPHARMACEUTICALS, INC.
- CIK
- CIK 810509
- Filed
- Dec 12, 2019
- Reporting period
- Dec 06, 2019
- Description
- Schedule 13D beneficial ownership